Skip to Content

Join the 'Doxorubicin' group to help and get support from people like you.

Doxorubicin News

FDA Grants Accelerated Approval to Lartruvo (olaratumab) for Advanced Soft Tissue Sarcoma

Posted 19 Oct 2016 by Drugs.com

October 19, 2016 – The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS), which are cancers that develop in muscles, fat, tendons or other soft tissues. Lartruvo is approved for use with the FDA-approved chemotherapy drug doxorubicin for the treatment of patients with STS who cannot be cured with radiation or surgery and who have a type of STS for which an anthracycline (chemotherapy) is an appropriate treatment. “For these patients, Lartruvo, added to doxorubicin, provides a new treatment option,” said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research and acting director of the FDA’s Oncology Center of Excellence. “This is the first new therapy approved by the FDA for the initial ... Read more

Related support groups: Cancer, Doxorubicin, Soft Tissue Sarcoma, Lartruvo, Olaratumab

Lartruvo (olaratumab) Approved for Soft-Tissue Cancers

Posted 19 Oct 2016 by Drugs.com

WEDNESDAY, Oct. 19, 2016 – Lartruvo (olaratumab) has been approved by the U.S. Food and Drug Administration to treat adults with certain soft-tissue sarcomas, cancers that develop in areas such as the muscles, fat, blood vessels and tendons. Lartruvo has been sanctioned for use with the chemotherapy drug doxorubicin in cases that cannot be treated with radiation or surgery, the FDA said Wednesday in a news release. More than 12,000 new cases of soft-tissue sarcoma are projected to be diagnosed this year and nearly 5,000 people are likely to die from the disease, the agency said, citing estimates from the U.S. National Cancer Institute. Lartruvo is designed to block cell receptors that fuel tumor growth, the FDA said. The drug was evaluated in clinical trials involving 133 people with soft-tissue carcinomas. Average survival among people who took Lartruvo and doxorubicin was 8.2 months, ... Read more

Related support groups: Cancer, Adriamycin, Soft Tissue Sarcoma, Doxorubicin, Dermatofibrosarcoma Protuberans, Rhabdomyosarcoma, Liposarcoma, Adriamycin RDF, Kaposi's Sarcoma, Adriamycin PFS

'Liquid Biopsy' May Show Whether Cancer Drugs Are Working

Posted 14 Jul 2016 by Drugs.com

WEDNESDAY, July 13, 2016 – Researchers have developed a blood test that might allow doctors to know quickly whether a cancer drug is working. The technique is in the early stages of testing, and not ready for "prime time," scientists said. But they were also hopeful that the research will help advance the use of so-called liquid biopsies in treating cancer. Doctors have long used invasive biopsy procedures to get tumor samples, study them, then use the information to make treatment decisions or monitor a patient's response to treatment. But those procedures can be uncomfortable and carry some risks, like bleeding and infection, said Dr. Erica Mayer, a breast cancer expert with the American Society of Clinical Oncology (ASCO). Plus, she noted, some tumors are difficult to reach, and some patients are not healthy enough to have an invasive biopsy. So there's been "great interest," Mayer ... Read more

Related support groups: Cancer, Breast Cancer, Lung Cancer, Tarceva, Breast Cancer, Prevention, Adriamycin, Diagnosis and Investigation, Doxorubicin, Breast Cancer - Palliative, Body Imaging, Adriamycin RDF, Adriamycin PFS

U.S. Pays Highest Prices for Cancer Meds: Study

Posted 6 Jun 2016 by Drugs.com

MONDAY, June 6, 2016 – The United States pays the highest prices in the world for generic and brand-name cancer drugs, a new study has found. However, as the world's wealthiest nation, the United States is better able to pay for those pricey drugs than poorer countries with somewhat lower medication prices, added study lead author Dr. Daniel Goldstein. People in China and India are much less able to afford cancer drugs than Americans, he said, even though U.S. monthly drug prices are about three to six times higher in the United States. That doesn't mean America came out on top in overall drug affordability, however. Developed nations such as Australia, England and Israel had the "best deal" in the world on cancer drugs, thanks to government programs that regulate drug pricing, the study found. "America is the wealthiest nation, but its drug prices are significantly higher – so much ... Read more

Related support groups: Cancer, Provera, Depo-Provera, Methotrexate, Breast Cancer, Accutane, Lupron, Tamoxifen, Medroxyprogesterone, Arimidex, Tretinoin, Fluorouracil, Lupron Depot, Femara, Gleevec, Colorectal Cancer, Lung Cancer, Isotretinoin, Rituxan, Claravis

Common Class of Breast Cancer Drugs May Not Trigger 'Chemo Brain': Study

Posted 21 Apr 2016 by Drugs.com

THURSDAY, April 21, 2016 – Some breast cancer patients complain of a fogged mental condition often called "chemo brain," experienced after their therapy. Now, new research suggests that at least one class of chemotherapy drugs, called anthracyclines, is not related to the debilitating condition. Anthracyclines include medications such as doxorubicin and epirubicin, among others. One expert not connected to the study said the findings should be reassuring for patients. Used in combination with other drugs, anthracyclines "have a long track record in the treatment of breast cancer and still are the preferred regimens, especially in younger, fit women with aggressive breast cancer such as triple-negative cancer," explained Dr. Nina D'Abreo. She is an oncologist at Winthrop-University Hospital in Mineola, N.Y. "It is encouraging to know that women who are felt to be most likely to benefit ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Adriamycin, Doxorubicin, Breast Cancer - Palliative, Epirubicin, Pharmorubicin RDF, Adriamycin RDF, Pharmorubicin PFS, Adriamycin PFS, Ellence

Fewer Childhood Cancer Survivors Dying From 'Late' Effects

Posted 13 Jan 2016 by Drugs.com

WEDNESDAY, Jan. 13, 2016 – Fewer childhood cancer survivors are dying years later from lingering effects of the treatment that conquered their cancer, a new study finds. Experts called the report, published in the Jan. 14 issue of the New England Journal of Medicine, "very good news." "The findings substantiate what experts in the field have hoped would be true," said lead researcher Dr. Gregory Armstrong, of St. Jude Children's Research Hospital, in Memphis, Tenn. Survival rates from many childhood cancers are high, but survivors still face what doctors call "late effects" – health problems that develop months to years after the cancer treatment has ended. Among U.S. children who survived cancer back in the 1970s and '80s, 18 percent died within the next 25 years, Armstrong said. Sometimes, the initial cancer comes back. Often though, the health issues are related to the very ... Read more

Related support groups: Cancer, Methotrexate, Fluorouracil, Xeloda, Hydroxyurea, Mercaptopurine, Hydrea, Carboplatin, Cisplatin, Cytoxan, Dacogen, Cyclophosphamide, Temodar, Bendamustine, Treanda, Oxaliplatin, Gemzar, Gemcitabine, Capecitabine, Hodgkin's Lymphoma

Furry Friends May Be Stress Relievers for Kids With Cancer

Posted 23 Oct 2015 by Drugs.com

FRIDAY, Oct. 23, 2015 – For kids battling cancer, relief from the stress of their situation may come on four legs, a new study shows. In the study, so-called "therapy dogs" seemed to provide these children with both physical and mental benefits. "The dog may have a calming effect on the patient," lead researcher Amy McCullough, national director of humane research and therapy at the American Humane Association, explained in a news release from the American Academy of Pediatrics (AAP). The study findings are scheduled to be presented Sunday at the AAP's annual meeting in Washington, D.C. In the study, McCullough's team looked at outcomes for 68 children, aged 3 to 17, who were newly diagnosed with cancer. The kids were divided into two groups, where one group received weekly visits from a therapy dog and the other group did not. As the authors explained, during the visits the children ... Read more

Related support groups: Anxiety and Stress, Cancer, Doxorubicin, Adriamycin, Mitomycin, Epirubicin, Daunorubicin, Doxil, Bleomycin, Plicamycin, Lipodox, Blenoxane, Nipent, Pentostatin, Cosmegen, Pharmorubicin PFS, Valrubicin, Valstar, Idamycin, Idamycin PFS

HPV-Linked Throat Cancer Responds to Reduced Chemo, Radiation: Study

Posted 22 Oct 2015 by Drugs.com

THURSDAY, Oct. 22, 2015 – Lower-level radiation and chemotherapy may be as effective as standard doses for some patients with human papillomavirus (HPV)-related cancer of the throat, tonsils and tongue, and may cause fewer side effects, researchers say. The study included 43 patients who had "favorable risk" HPV-associated oropharyngeal (tonsils and tongue) cancer and were not heavy smokers. Compared to standard treatment, their radiation therapy was reduced by 16 percent and their chemotherapy dose was reduced by 60 percent. After an average follow-up of nearly 21 months (range of 6 to 36 months), all of the patients were alive with no evidence of cancer recurrence, according to the report. The patients had fewer side effects – such as mouth dryness, swallowing problems, nausea, vomiting and inflammation of the membranes lining the digestive tract – compared with patients who ... Read more

Related support groups: Cancer, Head and Neck Cancer, Mitomycin, Adriamycin, Doxorubicin, Epirubicin, Doxil, Daunorubicin, Lipodox, Bleomycin, Plicamycin, History - Radiation Therapy, Blenoxane, Nipent, Cosmegen, Dactinomycin, Pharmorubicin PFS, Pentostatin, Valstar, Valrubicin

U.S. Oncologists Decry High Cost of Cancer Drugs

Posted 23 Jul 2015 by Drugs.com

THURSDAY, July 23, 2015 – Soaring costs for cancer drugs are hurting patient care in the United States, a group of top oncologists claim. "High cancer-drug prices are affecting the care of patients with cancer and our health care system," Dr. Ayalew Tefferi, a hematologist at Mayo Clinic in Rochester, Minn., said in a Mayo news release. Tefferi and his colleagues made a number of recommendations on how to address the problem in a commentary published July 23 in the Mayo Clinic Proceedings. Allowing Medicare to negotiate drug prices is one of the suggestions the team of 118 leading cancer experts offered as a possible solution. Along with their recommendations, the group also expressed support for a patient-based grassroots movement on change.org that is demanding action on the issue. "The average gross household income in the U.S. is about $52,000 per year. For an insured patient with ... Read more

Related support groups: Cancer, Provera, Depo-Provera, Methotrexate, Breast Cancer, Accutane, Lupron, Prostate Cancer, Tamoxifen, Medroxyprogesterone, Arimidex, Tretinoin, Fluorouracil, Lupron Depot, Femara, Gleevec, Colorectal Cancer, Lung Cancer, Renal Cell Carcinoma, Isotretinoin

Doctors May Play Big Role in Antibiotic Overuse: Study

Posted 20 Jul 2015 by Drugs.com

MONDAY, July 20, 2015 – Doctors, nurse practitioners and other health care workers who prescribe drugs may be helping to drive the overuse of antibiotics in the United States, new research suggests. Experts have long warned that using antibiotics for illnesses for which they are useless – viral infections, for example – helps foster resistance by germs to these potentially lifesaving drugs. In the new study, a team led by Dr. Barbara Jones, an assistant professor of internal medicine at the University of Utah, looked at data on more than 1 million patient visits for acute respiratory infections at 130 VA medical centers across the United States between 2005 and 2012. According to the U.S. National Institutes of Health, acute respiratory infections include the common cold, bronchitis and ear infections – many of which are caused by viruses. However, Jones' team found that antibiotics ... Read more

Related support groups: Influenza, Cold Symptoms, Swine Influenza, Viral Infection, Avian Influenza, Mitomycin, Adriamycin, Doxorubicin, Epirubicin, Doxil, Daunorubicin, Bleomycin, Lipodox, Plicamycin, Blenoxane, Nipent, Cosmegen, Dactinomycin, Lipodox 50, Pharmorubicin PFS

Could Antibiotics Raise a Child's Risk for Juvenile Arthritis?

Posted 20 Jul 2015 by Drugs.com

MONDAY, July 20, 2015 – Here's yet another reason not to overuse antibiotics: Children treated with the antibacterial drugs may face a greater risk for developing juvenile arthritis, new research suggests. The study found that children and teens prescribed antibiotics had about twice the risk of developing juvenile arthritis compared to children the same age who were not prescribed the drugs. "This risk was greatest within a year of receiving antibiotics and increased with the number of antibiotic courses children were prescribed," said study lead author Dr. Daniel Horton, a research fellow with the Rutgers Biomedical and Health Sciences Child Health Institute of New Jersey. Antifungal and antiviral drugs did not show the same effect, he said. The results suggest antibiotics may trigger juvenile arthritis in a small subset of children who are prone to developing this disease, Horton ... Read more

Related support groups: Metronidazole, Bactrim, Flagyl, Bactrim DS, Sulfamethoxazole/Trimethoprim, Xifaxan, Polymyxin B, Septra, Juvenile Rheumatoid Arthritis, Zyvox, Bacitracin, Rifaximin, Metro, SMZ-TMP DS, Septra DS, Sulfatrim, Chloramphenicol, Cotrimoxazole, Juvenile Idiopathic Arthritis, Flagyl IV

Antibiotics Myths Still Common Among Parents

Posted 20 Jul 2015 by Drugs.com

MONDAY, July 20, 2015 – Many American parents still have misconceptions about when their children should receive antibiotics and what the medications do, a new study finds. Looking at data results spanning more than a decade, researchers saw that parents with Medicaid insurance were more likely to misunderstand appropriate antibiotic use than parents with private commercial insurance. Medicaid is the government-run insurance program for lower-income Americans. "While not confirmed, it is possible that the combination of health literacy and underlying socioeconomic factors could contribute to both the misconceptions and expectations for antibiotics," said Dr. Louise Vaz. She is assistant professor of pediatric infectious diseases and medical director of the Outpatient Antibiotic Therapy Program at Oregon Health and Science University in Portland. "We do need to better tailor our ... Read more

Related support groups: Metronidazole, Influenza, Bactrim, Flagyl, Cold Symptoms, Bactrim DS, Sulfamethoxazole/Trimethoprim, Xifaxan, Polymyxin B, Septra, Zyvox, Swine Influenza, Bacitracin, Rifaximin, Metro, SMZ-TMP DS, Septra DS, Sulfatrim, Chloramphenicol, Cotrimoxazole

Appendicitis Can Often Be Treated With Antibiotics

Posted 16 Jun 2015 by Drugs.com

TUESDAY, June 16, 2015 – Although surgical removal of the appendix has long been a standard treatment, a new study found that almost three-quarters of people treated with antibiotics could be spared the invasive procedure known as appendectomy. "For more than a century, appendectomy has been the standard treatment," said the study's lead author Dr. Paulina Salminen, of Turku University Hospital in Finland. But about 80 percent of patients with an inflamed appendix, commonly called appendicitis, don't need to have their appendix surgically removed, and those who ultimately do need the surgery aren't hurt by waiting, according to Salminen. She thinks that this and other studies will change how appendicitis is treated. "Now we know that only a small proportion of appendicitis patients need an emergency operation," Salminen said. However, there are two types of appendicitis – one that ... Read more

Related support groups: Surgery, Metronidazole, Bactrim, Flagyl, Bactrim DS, Sulfamethoxazole/Trimethoprim, Xifaxan, Polymyxin B, Septra, Zyvox, Bacitracin, Rifaximin, Metro, SMZ-TMP DS, Septra DS, Sulfatrim, Chloramphenicol, Appendicitis, Cotrimoxazole, Flagyl IV

Doctors Can Cut Back on Antibiotics After Abdominal Surgery: Study

Posted 11 Jun 2015 by Drugs.com

THURSDAY, June 11, 2015 – The length of antibiotic treatment for abdominal infections can be cut in half and still be equally effective, a new study suggests. Doing so could help efforts to battle the growing problem of antibiotic resistance, the study authors said. The study – led by researchers at the University of Virginia – included more than 500 patients in the United States and Canada with abdominal infections. First, the source of the infection was treated, such as the removal of an inflamed appendix. After surgery, half of the patients took antibiotics for eight days. The other half took antibiotics for only four days. Outcomes in both groups were similar, the study found. "It's important for physicians to realize the most important aspect of the management of these patients is controlling the source of infection," Dr. Robert Sawyer, from the departments of surgery and ... Read more

Related support groups: Surgery, Metronidazole, Bactrim, Flagyl, Bactrim DS, Sulfamethoxazole/Trimethoprim, Xifaxan, Polymyxin B, Septra, Zyvox, Bacitracin, Rifaximin, Metro, SMZ-TMP DS, Septra DS, Sulfatrim, Chloramphenicol, Cotrimoxazole, Flagyl IV, Flagyl IV RTU

Germs in Foodborne Illness Gaining Resistance to Antibiotics, CDC Says

Posted 9 Jun 2015 by Drugs.com

TUESDAY, June 9, 2015 – Antibiotic resistance in foodborne germs remains a public health threat despite attempts to combat the problem, according to new U.S. government data. Antibiotic-resistant infections from foodborne germs still cause about 440,000 illnesses in the United States each year, the U.S. Centers for Disease Control and Prevention reported online Tuesday. "Antibiotic resistance can arise spontaneously, but the greatest contribution to antibiotic resistance is the overuse and overprescribing of antibiotics," said one expert, Dr. Len Horovitz, an internist at Lenox Hill Hospital in New York City. He was not involved in the new report. Testing in 2013 revealed that multidrug resistance – non-responsiveness to three or more classes of antibiotics – in salmonella infections remained steady, accounting for 10 percent of foodborne illnesses, the CDC said. But antibiotic ... Read more

Related support groups: Cipro, Ciprofloxacin, Ciprodex, Doxorubicin, Adriamycin, Mitomycin, Epirubicin, Salmonella Enteric Fever, Ciloxan, Cipro HC, Campylobacter Gastroenteritis, Salmonella Gastroenteritis, Cipro HC Otic, Plicamycin, Cipro XR, Bleomycin, Lipodox, Doxil, Cipro IV, Blenoxane

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer, Bronchogenic Carcinoma, Bladder Cancer, Soft Tissue Sarcoma, Acute Lymphoblastic Leukemia, Lymphoma, Osteosarcoma, Wilms' Tumor, Ovarian Cancer, view more... Thyroid Cancer, Stomach Cancer, Mantle Cell Lymphoma, Acute Myeloblastic Leukemia, Cancer, Hodgkin's Lymphoma, Multiple Myeloma, Neuroblastoma

Related Drug Support Groups

Adriamycin, Adriamycin PFS, Adriamycin RDF

Doxorubicin Patient Information at Drugs.com